Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma

In most myeloma patients, even after several rounds of intensive therapy, drug resistant tumor cells survive and proliferate aggressively leading to relapse. In the present study, gene expression profiling of tumor cells isolated from myeloma patients after sequential rounds of chemotherapy, reveale...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramani, Vishnu C., Zhan, Fenghuang, He, Jianbo, Barbieri, Paola, Noseda, Alessandro, Tricot, Guido, Sanderson, Ralph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811483/
https://www.ncbi.nlm.nih.gov/pubmed/26624982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811483/
https://www.ncbi.nlm.nih.gov/pubmed/26624982

Ejemplares similares